NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-183-2003-0-RU-18 Method For Treating Cognitve Disorders RU National Stage 2004131214 Abandoned
NCI E-299-2004-1-US-01 Soluble Forms Of The Crimean-Congo Hemorrhagic Fever (CCHF) Virus G1 And G2 Proteins US 60/620,833 Abandoned
NIAID E-227-2001-0-US-03 Brother of The Regulator of Imprinted Sites (Boris) US National Stage 10/505,377 7375206 Expired PDF
NICHD E-355-2003-2-US-02 Antileishmanial Sulfonamide Componds With Activity Against Parasite Tubulin US National Stage 10/512,335 Abandoned
NCI E-263-2004-0-US-01 POT1 Alternative Splicing Variants US 60/620,754 Abandoned
NCI E-311-2004-0-US-01 Methods and Compositions For Protecting Cells From Ultrasound Induced Cytolysis US 60/620,258 Abandoned
ORS E-190-2004-0-US-01 Apparatus and Method For Decontamination US 60/620,095 Abandoned
NIAID E-114-2006-0-US-01 Adenovirus Fiber Shaft Composition And Methods Of Use US 60/619,912 Abandoned
NCI E-293-2003-0-IT-10 COLORECTAL CANCER ANTIGEN IT EP 04790870.2 Abandoned
NCI E-293-2003-0-EP-04 COLORECTAL CANCER ANTIGEN EP National Stage 04790870.2 Abandoned
NCI E-293-2003-0-FR-08 COLORECTAL CANCER ANTIGEN FR EP 04790870.2 Abandoned
NCI E-293-2003-0-DE-07 COLORECTAL CANCER ANTIGEN DE EP 04790870.2 Abandoned
NCI E-293-2003-0-GB-09 COLORECTAL CANCER ANTIGEN GB EP 04790870.2 Abandoned
NIEHS E-163-2002-2-US-02 Compositions And Methods For Diagnostics And Therapeutics For Hydrocephalus US National Stage 10/511,362 8008463 Issued PDF
NCI E-293-2003-0-PCT-02 Colon Tumor Antigen COA-1 PCT PCT PCT/EP2004/012087 Expired
NCI E-100-2001-0-US-03 DIRECT CELL TARGET ANALYSIS US National Stage 10/511,511 Abandoned
NCI E-293-2003-0-JP-05 Colon Tumor Antigen COA-1 JP National Stage 2006534728 Abandoned
NCI E-091-2007-0-DK-19 MAL Variant Of LAV (HIV-1) Virus DK DIV 200401579 Expired
NCI E-293-2003-0-CA-03 Colon Tumor Antigen COA-1 CA National Stage 2542686 Abandoned
NCI E-272-2002-1-PCT-01 SERINE PROTEASE INHIBITORS PCT PCT PCT/US04/034108 Abandoned
NHLBI E-114-2004-0-US-01 Assay System And Composition Of Multi-domain Amphipathic Helical Peptides For The Treatment Of Atherosclerosis. US 60/619,392 Abandoned
NHLBI E-008-2005-0-US-01 Active Chromatin Domains Are Defined By Acteylation Islands Revealed By Genome-wide Mapping US 60/619,430 Abandoned
NINDS E-125-2004-0-US-01 METHOD OF ETCHING ISLANDS OF CELLS IN A GRID PATTERN US ORD 10/967,703 7276367 Abandoned PDF
NCI E-002-2002-1-US-02 Materials And Methods For Inhibiting WIP-1 US National Stage 10/507,701 Abandoned
NCI E-302-2004-0-US-01 A32 Monoclonal Antibody Fusion Protein For Use As HIV Inhibitors And Vaccines Vaccines US 60/618,820 Abandoned
NCI E-103-2002-0-US-03 METHODS FOR SEPARATION AND DETECTION OF KETOSTEROIDS AND OTHER CARBONYL-CONTAINING COMPOUNDS US National Stage 10/511,409 7807472 Issued PDF
NIAID E-356-2003-0-PCT-02 HIV/SIV ENV Chimeras that Promote Trimerization and Maintain Targets of Neutralizing Antibodies PCT PCT PCT/US2004/33505 Expired
NCI E-057-2002-2-US-02 Conjugates of Ligand, Linker And Cytotoxic Agent and Related Compositions and Methods of Use US National Stage 10/505,239 Abandoned
NCI E-221-1993-3-JP-25 Compositions and Methods for Treating and Preventing Pathologies Including Cancer JP DIV 2005-54744 Abandoned
NCI E-221-1993-3-JP-24 Compositions and Methods for Treating and Preventing Pathologies Including Cancer JP DIV 2005-54743 Abandoned
NCI E-185-2004-0-US-01 Tricyclic Carboxamides as Inhibitors of the Hypoxic Signaling Pathway US 60/618,279 Abandoned
NCI E-340-2004-1-US-01 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival US 60/617,768 Abandoned
NHLBI E-276-2004-1-US-01 Methods for Diagnosis of Atherosclerosis US 60/618,275 Abandoned
NCI E-221-1995-0-US-03 MHC-CLASS II RESTRICTED MELANOMA ANTIGENS AND THEIR USE IN THERAPEUTIC METHODS US DIV 10/962,143 7501501 Abandoned PDF
CC E-174-2003-0-US-02 Automated Identification of Ileocecal Valve US CIP 10/961,681 7440601 Issued PDF
NCI E-167-2003-0-PCT-02 Means For Identifying Differentially Expressed Macromolecules Through The Use Of Circulating Biomarker Attractant Molecules (BAM's) PCT PCT PCT/US2004/33305 Expired
NCI E-199-2002-0-EP-05 Depsipeptide For Therapy of Kidney Cancer EP National Stage 03715503.3 Abandoned
NCI E-340-2004-0-US-01 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival US 60/617,340 Abandoned
CC E-291-2004-0-US-01 Charge Neutralized Complexes Of Paramagnetic Metals As An Intracellular MRI Contrast Agent US 60/616,649 Abandoned
NIDCR E-160-2000-1-US-03 T2R, A NOVEL FAMILY OF TASTE RECEPTORS US CON 10/962,365 7465550 Expired PDF
NIBIB E-024-2004-0-US-02 A Microfludic Flow-Through Immunoassay For A Simultaneous Detection Of Multiple Proteins In A Sub-Microliter Bioligical Sample US ORD 10/882,188 Abandoned
NEI E-328-2004-0-US-01 The Use Of High Dose Anti-IL2 Receptor Antibody To Treat Acutely Active Sight Threatening Non Infectious Uveitis US 60/616,760 Abandoned
NCI E-244-2002-0-PCT-02 Glioma-Selective Polypeptides, Alone Or Coupled To a Therapeutic/Diagnostic Agent, Compositions Comprising Same, and Uses Thereof PCT PCT PCT/US2004/32971 Expired
NCI E-199-2002-0-US-04 Depsipeptide For Therapy of Kidney Cancer US National Stage 10/508,958 8673888 Expired PDF
NIAID E-355-2001-2-US-02 VAC-BAC Shuttle Vector System US National Stage 10/959,392 7494813 Issued PDF
NCI E-199-2002-0-JP-08 Depsipeptide For Therapy of Kidney Cancer JP National Stage 2003-581847 Abandoned
NCI E-281-2003-1-US-01 Identification Of A G-Protein Coupled Receptor, FPR, As A Functional Receptor For The Leukocyte Chemotactic Activity Of The Neutrophil Granule Protein Cathepsin G (CaG) US 60/615,607 Abandoned
NCI E-323-2004-0-US-01 Arylthioindole Tubulin Polymerization Inhibitors and Methods of Treating or Preventing Cancer Using Same US 60/616,347 Abandoned
NIDCR E-229-2004-0-PCT-02 Mammalian T1R3 Sweet Taste Receptors PCT PCT PCT/US2004/032678 Abandoned
NIDCR E-229-2004-0-JP-07 Mammalian T1R3 Sweet Taste Receptors JP National Stage 2006-534237 Abandoned